NCT00265018View on ClinicalTrials.gov

HD10 for Early Stages

PHASE3CompletedINTERVENTIONAL

Enrollment

1,370

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

January 31, 2003

Conditions

Hodgkin´s Lymphoma

Interventions

DRUG

Adriamycin

DRUG

Bleomycin

DRUG

Vinblastine

DRUG

DTIC

RADIATION

30 Gy IF-RT

RADIATION

20 Gy IF-RT

All Listed Sponsors

lead

University of Cologne

OTHER

NCT00265018 - HD10 for Early Stages | Biotech Hunter | Biotech Hunter